Ultralife Corporation
ULBI
$6.13
-$0.25-3.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 48.48M | 43.37M | 48.56M | 50.75M | 43.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 48.48M | 43.37M | 48.56M | 50.75M | 43.85M |
| Cost of Revenue | 36.43M | 33.75M | 36.94M | 37.94M | 33.25M |
| Gross Profit | 12.06M | 9.62M | 11.62M | 12.81M | 10.60M |
| SG&A Expenses | 11.07M | 7.12M | 6.89M | 6.82M | 8.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.32M | 43.73M | 46.15M | 47.16M | 43.99M |
| Operating Income | -1.84M | -357.00K | 2.41M | 3.58M | -137.00K |
| Income Before Tax | -10.21M | -1.75M | 1.11M | 2.45M | 495.00K |
| Income Tax Expenses | -2.75M | -504.00K | 243.00K | 567.00K | 262.00K |
| Earnings from Continuing Operations | -7.45M | -1.25M | 870.00K | 1.88M | 233.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 31.00K | 27.00K | 9.00K | -14.00K | -39.00K |
| Net Income | -7.42M | -1.22M | 879.00K | 1.87M | 194.00K |
| EBIT | -1.84M | -357.00K | 2.41M | 3.58M | -137.00K |
| EBITDA | -530.00K | 1.06M | 3.83M | 4.94M | 1.04M |
| EPS Basic | -0.45 | -0.07 | 0.05 | 0.11 | 0.01 |
| Normalized Basic EPS | -0.05 | -0.04 | 0.05 | 0.10 | -0.04 |
| EPS Diluted | -0.45 | -0.07 | 0.05 | 0.11 | 0.01 |
| Normalized Diluted EPS | -0.05 | -0.04 | 0.05 | 0.10 | -0.04 |
| Average Basic Shares Outstanding | 16.65M | 16.65M | 16.64M | 16.63M | 16.63M |
| Average Diluted Shares Outstanding | 16.65M | 16.65M | 16.66M | 16.68M | 16.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |